7361 - 7370 of 7939 Results
Title
Year
-
OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: https://europepmc.org/articles/pmc4208292?pdf=renderCitation Count: 141
-
RESTRICTEDTitle: Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1084End Page: 1088Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.007Citation Count: 85
-
OPENTitle: Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1089End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.008Best OA location URL: http://www.prd-journal.com/article/S1353802012002465/pdfCitation Count: 59
-
OPENTitle: Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress responseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 6Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07860.xBest OA location URL: https://europepmc.org/articles/pmc4135048?pdf=renderCitation Count: 18
-
OPENTitle: Serotonin transporter inhibition attenuates l‐DOPA‐induced dyskinesia without compromising l‐DOPA efficacy in hemi‐parkinsonian ratsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 36Issue #: 6Start Page: 2839End Page: 2848Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2012.08202.xBest OA location URL: https://europepmc.org/articles/pmc3445783?pdf=renderCitation Count: 70
-
OPENTitle: Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 523End Page: 530Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182635645Best OA location URL: https://europepmc.org/articles/pmc3413767?pdf=renderCitation Count: 164
-
OPENTitle: Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 141Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3003985Best OA location URL: https://europepmc.org/articles/pmc3462009?pdf=renderCitation Count: 470
-
OPENTitle: Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 3Start Page: 243End Page: 248Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31825fdeedBest OA location URL: https://europepmc.org/articles/pmc3398434?pdf=renderCitation Count: 109
-
RESTRICTEDTitle: Animal models of Parkinson's disease: Limits and relevance to neuroprotection studiesJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 1Start Page: 61End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25108Best OA location URL: https://europepmc.org/articles/pmc3517687?pdf=renderCitation Count: 162
-
OPENTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://europepmc.org/articles/pmc3589103?pdf=renderCitation Count: 47